| PUBLICAÇÕES
1.
Schechter, M.; Flint, JE; Voller, A; Guhl,
F; Marinkelle, CJ; Miles, MA. Purified Trypanosoma cruzi glycoprotein
for discriminative serological diagnosis of South American
Trypanosomiasis (Chagas' Disease). The Lancet 1984; ii: 939-941.
2. Flint, JE; Schechter, M; Chapman, MD;
Miles, MA. Zymodeme and species specificities of monoclonal
antibodies raised against T. cruzi. Trans R Soc Hyg Trop Med
1984; 78: 193-202.
3. Schechter, M; Luquetti, AO; Rezende, JM;
Rassi, A, Miles, MA. Further evaluation of a lectin affinity
purified glycoprotein (GP90) in the Enzyme Linked Immunosorbent
Assay (ELISA) for the diagnosis of T. cruzi infection. Trans
R Soc Hyg Trop Med 1985; 79: 637-640.
4. Schechter, M; Stevens, AF; Allen, AK;
Miles, MA. Investigations on the expression of a 72,000 molecular
weight surface glycoprotein (GP72) in T. cruzi zymodemes and
detection of anti-GP72 antibodies in Chagasic patients. Trans
R Soc Hyg Trop Med 1985; 79: 131.
5. Schechter, M; Stevens, AF; Luquetti, AO;
Snary, D; Allen, AK; Miles, MA. Prevalence of antibodies to
a 72 Kilodalton glycoprotein (GP72) in patients with Chagas'
disease and further evidence for zymodeme associated expression
of GP72 carbohydrate epitopes. Infection and Immunity 1986;
53(3): 547-552.
6. Scharfstein, J; Schechter, M; Senna, M;
Peralta, JM; Mendonca-Previato, L; Miles, MA. Trypanosoma
cruzi: Characterization and isolation of a 57/51,000 mw surface
glycoprotein (GP57/51) expressed by epimastigotes and bloodstream
trypomastigotes. J Immunol 1986; 137 (4): 1336-1341.
7. Schechter, M. Evaluation of a monoclonal
antibody affinity purified antigen for zymodeme specific serological
diagnosis of Trypanosoma cruzi infection. Mem Inst Oswaldo
Cruz 1987; 82(1): 81-85.
8. Schechter, M; Nogueira, N. Variations
induced by different methodologies in Trypanosoma cruzi surface
antigen profiles. Mol Biochem Parasitol 1988; 29: 37-46.
9. Puccioni, M; Schechter, M; Ramos-Filho,
C; Freitas, MRG; Novis, SAP. Neuropatia periférica
e infecção pelo vírus da imunodeficiência
humana. Rev Bras Neurol 1990; 26(6): 170-172.
10. Schechter, M; Pannain, VLN; Oliveira,
AV. Papovavirus associated esofageal ulceration in a patient
with AIDS. AIDS 1991; 5(2): 238.
11. Pinho, AMF; Marangoni, DV; Moreira, BM; Rodrigues, KM;
Paz, NA; Ramos-Filho, CF; Schechter, M. Bacteriuria
in patients with CDC group IV manifestations : A prospective
study. AIDS 1991; 5(3): 342.
12. Andrade, VL; Avelleira, JC; Marques, A; Vianna, FR; Schechter,
M. Leprosy as a cause of false positive results in
serological assays for the detection of antibodies to HIV-1.
Int. J Leprosy 1991; 59 (1): 125-126.
13. Puccioni, M; Correa, RB; Perez, MA; Schechter,
M; Ramos-Filho, C; Novis, SAP. Complicações
neurológicas na síndrome de imunodeficiência
adquirida. Arq Neuro-Psiquiatria 1991; 49 (2): 159-163.
14. Rodrigues, KMP; Puccioni-Sohler, M; Castineiras, TMPP;
Papi JA; Schechter, M; Avila, C; Duarte,
F; Novis, SAP. Miopatia e AIDS: Relato de um caso e revisão
de literatura. Arq de Neuropsiquiatria 1991; 49 (3): 352-356.
15. Schechter, M; Teixeira, MLB; Carvalho,
ACC; Peres, M. Pulmonary tuberculosis in sputum-negative Brazilian
AIDS patients. Chest 1992; 101 (4):1184.
16. Pasternak, J; Baldy, JLS; Schechter, M
Avaliação comparativa de eficacia e segurança
de cefadroxil e cefalexina no tratamento de penumonia bacteriana
de origem comunitaria em adultos. Arq Bras Med 1992; 66 (5).
17. Vaisman, M; Monteiro, CB; Feijo, P; Schechter,
M; Tendrich, M. Associação de Diabetes
Insipidus central e AIDS. Arq Bras Endocrinol Metabol. 1992;
36 (2): 60-61.
18. Cavalcanti, M; Ferreira-Jr, O; Puccioni, M; Novis, SAP;
Schechter, M. HTLV I associated neurological
manifestations in 4 generations of a Brazilian family. J Acq
Immun Def Synd 1993; 6 (2): 213-217.
19. Lima, LAA; May, SB; Perez, MA; Schechter, M.
Survival of HIV-infected Brazilian individuals: a model based
on the World Health Organization staging system. AIDS 1993;
7:295-296.
20. Zajdenverg, R; Valle, SOR; Silva, RFF; Baptista, AA; Schechter,
M. PPD reactivity and risk of development of tuberculosis
in HIV infected brazilian patients. Chest 1993; 104 (2): 646.
21. Collareda, NL; Frota, AC; Silva-Oliveira, RH; Schechter,
M. Breast-feeding and vertical transmission of HIV-1
in Rio de Janeiro, Brazil. Pediatric AIDS and HIV Infection
1993; 4 (4):195-197.
22. Durovni, B; Pinto, M; Schechter, M. AIDS
case definitions in developing countries. Lancet 1993; 342
(ii): 1054.
23. Pinto, ME; Carvalho, AP; Nogueira, C; Ferreira-Jr O, Schechter,
M. Prevalence of antibodies to Hepatitis C virus
in populations at low and high risk for Sexually transmitted
diseases in Rio de Janeiro, Brasil. Mem Inst Oswaldo Cruz
1993; 88(2): 305-307.
24. Schechter, M; Harrison, LH; Halsey, NA;
Trade, G; Santino, M; Moulton, LH; Quinn, TC. Co-infection
with Human T-Cell Lymphotropic Virus Type I and HIV in Brazil:
Impact on CD4 Lymphocyte counts and Clinical Stage. JAMA 1994;
271:353-357.
25. Schechter, M; Zajdenverg, R; Machado,
LL; Pinto, ME; Lima, LAAL; Perez, MA. Predicting CD4 counts
in HIV-infected Brazilian individuals: a model based on the
World Health Organization staging system. J Acq Immun Def
Synd 1994; 7:163-168.
26. Pinho, AMF; Lopes, GS; Ramos-Filho, CF; Santos, OR; Oliveira,
MPB; Halpern, M; Schechter, M. Urinary tract
infection in men with AIDS. GenitoUrin Med 1994; 70:30-34.
27. Hofer, CB; Pinto, ME; Zajdenverg, R; Schechter,
M. P24 antigenemia in HIV-1 infected brazilian individuals
correlates with other markers of disease progression. J Infection
1994; 29:129-131.
28. Groupe International de Travail sur la transmission mère-enfant
du VIH. Estimation du taux de transmission du VIH de la mère
à lénfant: problèmes métodologiques
et estimations actuelles. Cahiers SantÇ 1994; 4:73-86.
29. Nucci, M; Schechter, M; Spector, N; Pulcheri,
W; Caiuby, MJ; Morais, JC; Maceira J; Carvalho, DM; Oliveira,
HP. Antibiotic regimen as an independent risk factor for disseminated
fungal infections in neutropenic patients. Trans R Soc Hyg
Trop Med 1995. 89: 107-110.
30. Costa, SM; Shindo, N; Vicente, ANP; Pinto, ME; Schechter,
M; Tanuri, A. Full sequence of GP120 of an HIV-1
variant (GWGR) highly prevalent in Brazil. AIDS Res Hum Retrovirus
1995. 11(9):1143-1145.
31. The Working Group on Mother-To-Child Transmission of HIV.
Rates of mother-to-child transmission of HIV-1 in Africa,
America and Europe. Results from 13 perinatal studies. J Acquir
Immune Defic Synd 1995. 8 (5): 506-510.
32. Pieniazek, D; Janini, LM; Ramos, A; Tanuri, A; Schechter,
M; Peralta, JM; Vicente, ACP; Pieniazek, NJ; Schochetman,
G; Rayfield, M. HIV-1 patients harbor viruses belonging to
different subtypes: implication for the evolution of the pandemic.
Emerging Infect Dis 1995. 1 (3): 86-88.
33. Kritski, A; Dalcomo, M; del Bianco, R; Melo, FF; Pinto,
WP; Schechter, M; Castelo, A. Associação
de tuberculose e infecção pelo HIV no Brasil.
Bol Oficina Sanit Panam 1995. 118(6): 542-555.
34. Nardelli, B; Gonzales, CJ; Schechter, M;
Valentine, FT. CD4+ blood lymphocytes are rapidly killed in
vitro by contact with autologous immunodeficiency virus-infected
cells. Proc Nac Acad Sci USA 1995. 92: 7312-7316.
35. Pinto, ME; Schechter, M. V3 peptide binding
pattern and HIV-1 transmission route in Rio de Janeiro. Mem
Inst Oswaldo Cruz 1995; 90(6): 683-685.
36. Nogueira, CM; Cavalcanti, M; Schechter, M;
Ferreira-Jr, OC. Human T-Lymphotropic Virus Type I and II
in Healthy Blood Donors in Rio de Janeiro, Brazil. Vox Sag
1996:70;47-48.
37. Janini LM, Pieniazek D, Peralta JM, Schechter
M; Tanuri A; Vicente ACP; Torre LD; Pieniazek NJ;
Luo CC; Kalish ML; Schochetman G; Rayfield MA. Identification
of single and dual infections with distinct subtypes of human
immunodeficiency virus type 1 by using restriction fragment
length polymorphism analysis. Virus Genes 1996;13:69-81.
38. Gav_o-castro, B; Couto-fernandez, JC; Mello, MA; Linhares,
MIC; Castello-Branco, LR; Bongertz, V; Ferreira, PCP; Morgado,
M; Sabino, E; Tanuri, A.; Carvalheiro, J; Sutmoller,F; Simonetti,
JP; Schechter, M; Demacedo, LFB; Ueda, M.
A nationwide effort to systematically monitor HIV-1 diversity
in Brazil: preliminary results. Mem Inst Oswaldo Cruz 1996.
91(3):335-338.
39. Harrison, LH; Vaz, B; Taveira, DM; Quinn, TC; Gibbs, CJ;
Souza, SH; McArthur, JC; Schechter, M. Myelopathy
Among Brazilians Coinfected with Human T-Cell Lymphotropic
Virus Type I and HIV. Neurology 1997; 48:13-17.
40. Harrison, LH; Quinn, TC; Schechter, M.
Human T-Cell Lymphotropic Virus Type I Does Not Increase HIV
Viral Load in Vivo. J Infect Dis 1997; 175:438-440.
41. Schechter, M. The future of tropical
medicine: a Brazilian perspective. Lancet 1997; 349 (suppl
III);29-30
42. Harrison, LH; Schechter, M. Human T cell
Lymphotropic Virus Type II and Human Immunodeficiency Virus
Type I Disease Progression. J Infect Dis (letter). J Infect
Dis 1997; 176: 308.
43. Harrison, LH; Quinn, TC; Schechter, M.
Coinfection with Human T Lymphotropic Virus Type I and Human
Immunodeficiency Virus (letter). J Infect Dis 1997; 176: 544-545.
44. Respess, RA; Butcher, A; Wang, H; Chaowanachan, T; Young,
N; Shaffer, N; Mastro, TD; Biryahwaho, B; Downing, R; Schechter,
M; pascu, R; Zekeng, L; Kaptue, L; Gurtler, L; Eberle,
J; Ellenberger, D; Fridlund, C; Rayfield, M; Kwok, S. Detection
of genetically diverse Human Immunodeficiency Virus Type I
group M and O isolates by PCR. J Clin Microbiol 1997; 35(5):1284-1286.
45. Schechter, M; Moulton, LH; Harrison,
LH. HIV Viral Load and CD4+ Lymphocyte Counts in Subjects
Coinfected with HTLV-1 and HIV-1. J AIDS 1997; 15:308-311.
46. Harrison, LH; Schechter, M. Myelopathy
among brazilians coinfected with human T-cell lymphotropic
virus type I and HIV (letter). Neurology 1997; 49:1191.
47. Janini, LM; Tanuri, A; Schechter, M;
Peralta, JM; Vicente, ACP; Torre, ND; Pieniazek, NJ; Luo,
CC; Ramos, A; Soriano, V; Schochetman, G; Rayfield, M; Pieniazek,
D. Horizontal and vertical transmission of HIV-1 dual infections
caused by viruses of subtypes B and C. J Infect Dis 1998;177:227-231.
48. Harrison, LH; Schechter, M. Coinfection
with HTLV-I and HIV: Increase in HTLV-I-related outcomes but
not accelerated HIV disease progression? AIDS Patient Care
and STDs 1998; 12:619-623.
49. Pinto, ME; Tanuri, A; Schechter, M. Molecular
and epidemiologic evidence for the discontinuous introduction
of subtypes B and F into Rio de Janeiro, Brazil. J Acq Immun
Def Synd 1998; 19:310-312.
50. Zhang, X; Fitzpatrick, L; Campbell, TB; Badaro, R; Schechter,
M; Melo, MF; Brites, C; Sampaio, DP; Schooley, RT.
Comparison of the Prevalence of Antibodies to Human herpesvirus-8
(Kaposi's Sarcoma- Associated Herpesvirus) in Brazil and in
the United States. J Infect Dis 1998;178(5):1488-1491.
51. Lopes, GS; Harrison, LH; Lawrence, LH; Lima, LAA; Pinho,
AMF; Hofer, CB; Schechter, M. Gender and
Survival after AIDS in Rio de Janeiro, Brazil. J Acq Immun
Def Synd 1998; 19(4):403-407.
52. Schechter, M; Struchiner, CJ; Harrison,
LH. Protease Inhibitors as Initial Therapy for Individuals
with an Intermediate Risk of HIV Disease Progression: Is More
Necessarily Better?. AIDS 1999; 13:97-102.
53. Ramos, A; Tanuri, A; Schechter, M; Rayfield,
MA; Hu, DJ; Cabral, MC; Bandea, CI; Baggs, J;Pieniazek, D.
Dual and Recombinant Infections: An Integral Part of the HIV
Epidemic in Brazil. Emerging Infect Dis 1999; 5(1): 65-74.
54. Harrison, LH; Lago, R; Friedman, RK; Rodrigues, J; Santos,
EM; Moulton, LH; Schechter, M. Incident HIV
Infection in A High-Risk, Homosexual Male Cohort in Rio de
Janeiro, Brazil. J Acq Immun Def Synd 1999;21:408-412
55. Tanuri, A; Vicente, AC; Otsuki, K; Ramos, CA; Ferreira,
OC Jr; Schechter, M; Janini, LM; Pieniazek,
D; Rayfield, MA. Genetic variation and susceptibilities to
protease inhibitors among subtype B and F isolates in Brazil.
Antimicrob Agents Chemotherapy 1999. 43(2):253-8.
56. Schechter, M; Harrison, LH. Therapy of
early HIV infection: Time for the pendulum to swing back ?
AIDS Clinical Care 1999. 11(10):79-86.
57. Carpenter, CCJ; Cooper, DA; Fischl, MA; Gatell, JM; Gazzard,
BG; Hammer, SM; Hirsch, MS; Jacobsen, DM; Katzenstein, DA;
Montaner, JSG; Richman, DD; Saag, MS; Schechter, M;
Schooley, RT; Thompson, MA; Vella, SV; Yeni, PG; Volberding,
PA. Antiretroviral Therapy for HIV Infection: Updated Recomendations
of the International AIDS Society-USA Panel. JAMA 2000. 283(3):381390
58. Gordin, FM; Chaisson, RE; Matts, JP; Miller, C; Valdespino,
JL; Hafner, R; Garcia, L; Coberly, J; Schechter, M;
Klukowitz, AJ; Barry, A; O'Brien, RJ. An international, randomized
trial of Rifampin and Pyrazinamide versus Isoniazid for prevention
of tuberculosis in HIV-infected persons. JAMA 2000. 283 (11):
1445-1450.
59. Santoro-Lopes, G; Harrison, LH; Tavares, MD; Xexço,
A; Santos, ACE; Schechter, M. HIV-Disease
Progression and V3 serotypes in Brazil: Is B Different from
B-Br?. AIDS Res and Human Retrov 2000. 16(10): 953-958.
60. Barroso, PF; Schechter, M; Gupta, P;
Melo, FM; Vieira, M; Murta, F; Souza, Y; Harrison, LH. Effect
of Antiretroviral Therapy on HIV Shedding in Semen. Ann Int
Med 2000. 133:280-284
61. Schechter, M; Lago, RF; Melo, MF; Moreira,
RI; Faulhaber, JC; Batista, S; Harrison, LH. Identification
of a High-Risk, Heterosexual Population for HIV Prevention
Trials in Rio de Janeiro, Brazil. J Acq Immun Def Synd 2000.
24:175-7
62. Hofer, CB; Harrison, LH; Struchiner, CJ; Moreira, RI;
Lago, RF; Melo, MF; Schechter, M. Acute Retrovirus
Syndrome among Prospectively-Identified Homosexual Males with
Incident HIV Infection in Brazil. J Acq Immun Def Synd 2000.
25(2):188-191.
63. Perisse, A; Schechter, M; Moreira, RI;
Lago, RF; Santoro-Lopes, G; Harrison, LH. Willingness to Participate
in HIV Vaccine Trials among Men Who Have Sex with Men in Rio
de Janeiro, Brazil. J AIDS 2000;25:459-463.
64. Pinho, AMF; Santoro-Lopes, G; Harrison, LH; Schechter,
M. Chemoprophylaxis for tuberculosis and survival
of HIV-infected patients in Brazil. AIDS 2001;15:2129-2135.
65. Santoro-Lopes, G; Pinho, AMF; Harrison, LH; Schechter,
M.. Reduced Risk of Tuberculosis among Patients with
Advanced HIV Infection Treated with HAART in a Brazilian Cohort.
Clin Infect Dis 2002; 34:543-546.
66. Martin, DF; Sierra-Madero, J.; Walmsley, S.; Wolitz, R.A.;
Macey, K.; Georgiou, P.; Robinson, C.A.; Stempien, M.J.; and
the Valganciclovir Study Group. A Controlled Trial of Valganciclovir
as Induction Therapy for Cytomegalovirus Retinitis. N Engl
J Med 2002; 15: 119-1126.
67. Yeni, PG; Hammer, SM; Carpenter, CCJ; Cooper, DA; Fischl,
MA; Gatell, JM; Gazzard, BG; Hirsch, MS; Jacobsen, DM; Katzenstein,
DA; Montaner, JSG; Richman, DD; Saag, MS; Schechter,
M; Schooley, RT; Thompson, MA; Vella, Stefano; Volberding,
PA. Antiretroviral Treatment for Adult HIV Infection in 2002
Updated Recommendations of the International AIDS Society-USA
Panel. JAMA, 2002; 288:222-235.
68. Hammer, SGD; Havlir, D; Mofenson, L; Van Beek, I; Vella,
S; Chebet, L; Dybul, M; Giaquinto, C; Katabira, E; Katlama,
C; Kazatchkine, M; Malkin, JE; Mcintyre, C; M''Boup, S; Mokhbat,
J; Mukherjee, J; Phanupak, P; Schechter, M;
Avila Vittoria, M. Scaling up Antiretroviral Therapy in Resource-Limited
Settings: Guidelines for a public health approach. World Health
Organization, 2002.
69. Schechter, M. HIV vaccine evaluation
center in Rio de Janeiro, Brazil. Vaccine 2002. 6;20(15):1909-11.
70. Barroso, PF; Schechter, M; Gupta, P;
Bressan, C; Bonfim, A; Harrison, LH. Adherence to Antiretroviral
Therapy and Persistence of HIV RNA in Semen. Journal of Acquired
Immune Deficiency Syndromes 2003; 32:435-440.
71. A Safety Study of Oral Valganciclovir Maintenance Treatment
of Cytomegalovirus Retinitis. Roche Valganciclovir Study Group.
Journal of Acquired Immune Deficiency Syndromes, 2002; 30:392-400.
72. Hammer, SGD; Havlir, D; Klement, E; Scano, F; Malkin,
JE; Delfraissy, JF; Lange, J; Mofenson, L; Harrington, M;
Schechter, M; Kumarasamy, N; Duirier, N;
Sow, PS; Banoo, S; Macharia, T. Scaling up Antiretroviral
Therapy in Resource-Limited Settings: Guidelines for a public
health approach, 2003 revision. World Health Organization,
2003 (http://www.who.int/3by5/publications/documents/arv_guidelines/en/).
73. Cook RL, May S, Harrison LH, Moreira RI, Ness RB, Batista
S, Bastos M, Schechter M. High prevalence
of sexually transmitted diseases in young women seeking HIV
testing in Rio de Janeiro, Brazil. Sex Transm Dis 2004;31:67-72.
74. Schechter, M; Lago, RF; Mendelsohn, AB;
Moreira, RI; Moulton, LH; Harrison, LH. Behavioral Impact,
Acceptability, and HIV Incidence Among Homosexual Men With
Access to Post-Exposure Chemoprophylaxis for HIV. Journal
of Acquired Immune Deficiency Syndromes 2004;35:519-525.
75. Hofer, CB; Schechter, M; Harrison, LH.
Effectiveness of Antiretroviral Therapy among Patients Who
Attend Public HIV Clinics in Rio de Janeiro, Brazil. Journal
of Acquired Immune Deficiency Syndromes 2004; 36:967-971.
76. Barroso, PF; Harrison, LH; Melo, MF; Batista, S; Bastos
M; Faulhaber J; Moreira RI; Lago RF; Schechter M.
Identification of a high-risk heterosexual cohort for HIV
vaccine efficacy trials in Rio de Janeiro, Brazil, using a
sensitive/less sensitive assay: An Update. Journal of Acquired
Immune Deficiency Syndromes 2004;36:880-881.
77. Vibhagool, A; Cahn, P; Schechter, M;
Smaill, F; Soto-Ramirez, L; Carosi, G; Montroni, M; Pharo,
CE; Jordan, JC; Thomas, NE; Pearce, G. Triple Nucleoside Treatment
with Abacavir Plus the Lamivudine/Zidovudine Combination Tablet
(COM) Compared to Indinavir/COM in Antiretroviral Therapy-naïve
Adults: Results of a 48-Week Open-label, Equivalence Trial.
Current Medical Research and Opinion 2004;20: 1103-114.
78. Cahn, P; Vibhagool, A; Schechter, M;
Soto-Ramirez, L; Carosi, G; Smaill, F; Jordan, JV; Pharo,
CE; Thomas, NE; Steel, HM. Predictors of adherence and virologic
outcome in HIV-infected patients treated with abacavir- or
indinavir-based triple combination HAART also containing lamivudine/zidovudine.
Current Medical Research and Opinion 2004;20:1115-1123.
79. Yeni, PG; Hammer, SM;Hirsch, MS; Saag, MS; Schechter,
M; Carpenter, CCJ; Fischl, MA; Gatell, JM; Gazzard,
BG; Jacobsen, DM; Katzenstein, DA; Montaner, JSG; Richman,
DD; Schooley, RT; Thompson, MA; Vella, S; Volberding, PA.
Treatment for adult HIV infection: 2004 recommendations of
the International AIDS Society-USA Panel. JAMA 2004;251-265
80. Schechter M. Therapy of early HIV infection:
How far back should the pendulum swing? J Infect Dis J 2004;190:1043-5.
81. Leth, FV; Phanuphak, P; Stroes, E; Gazzard, B; Cahn, P;
Wood, R; Bloch, M; Katlama, C; Kastelein, JJP; Schechter,
M; Murphy, R; Horban, A; Hall, D; Raffi, F; Lange,
JMA; Reiss, P. Nevirapine and efavirenz elicit different changes
in lipids and lipoproteins in antiretroviral therapy naive
HIV-1 infected patients. PloS Med 2004; 1(1)e19: 64-74.
82. Coplan, PM; Gupta, SB; Dubey, AS; Pitisuttithum, P; Nikas,
A; Mbewe, B; Vardas, E; Schechter, M; Kallas,
EG; Freed, DC; Fu, TM; Mast, CT; Puthavathana, P; Kublin,
J; Collins, KB; Chisi, J; Pendame, R; Thaler, SJ; Gray, G;
Mcintyre, J; Straus, WL; Condra, JH; Mehrotra, DV; Guess,
H_; Emini, EA; Shiver, JW. Cross-Reactivity of Anti-HIV-1
T-Cell Immune Responses Among the Major HIV-1 Clades in HIV-positive
Individuals from Four Continents. J Infect Dis 2005;191:1427-1434
PUBLICAÇÕES
EM REVISTAS DE DIVULGAÇÃO CIENTÍFICA
83. Ministério da Saúde. Revisão da definiçãoo
nacional do caso de AIDS em adultos. Boletim do Ministério
da Saúde, Programa Nacional de Doenças sexualmente
transmissíveis/AIDS 1992.
84. Schechter, M. AIDS. Ars Curandi 1993;
6: 20-32.
85. Schechter, M. O que há de novo
em vacinas contra a AIDS. Vitrô 1993; 1(2): 8-11.
86. Durovni, B; Pinto, M; Schechter, M. Avaliação
da performance de 5 definições de casos de AIDS.
AIDS, Boletim Epidemiológico. Ministério da
Saúde, Programa Nacional de Doenças sexualmente
transmissíveis/AIDS 1993; VI(11): 2-4.
87. Schechter, M. Perspectivas para o desenvolvimento
de vacinas contra a AIDS. Ciência Hoje 1994; 17(101):
54-57.
88. Schechter, M. AIDS: As vacinas. Ciência
Hoje das Criancas 1995; 8(48): 4-5.
89. Schechter, M. Coinfecção
por HIV e HTLV-1. Ars Curandi 1995; 9 (28): 33-36.
90. Costa, MM; Walker, APG; Schechter, M.
Doenças infecto-contagiosas e amamentação.
Feminina 2000; 28(4): 187-190.
91. Schechter, M. HIV Treatment and Care
in Resource-Limited Settings. Medscape 2003.
92. Schechter, M. Scaling Up Antiretroviral
Therapy for Developing Countries - We Can Walk and Chew Gum
at the Same Time. Medscape 2003.
93. Rachid, M; Schechter, M. Medicamentos
anti-retrovirais e drogas recreativas: Interações
medicamentosas. Pr†tica Hospitalar 2004;VI(34):98-100.
EDITORAÇÃO DE LIVROS
94. Doenças Infecciosas: Conduta diagnóstica
e terapêutica. Schechter, M & Marangoni,
DV, editores. Editora Guanabara Koogan, Rio de Janeiro, 1994.
95. Manual de HIV/AIDS. Rachid, M & Schechter,
M. Editora Revinter, Rio de Janeiro, 1996.
96. Manual de HIV/AIDS. Rachid, M & Schechter,
M. Editora Revinter, Segunda Edição,
Rio de Janeiro, 1997.
97. Manual de HIV/AIDS. Rachid, M & Schechter,
M. Editora Revinter, Terceira Edição,
Rio de Janeiro, 1998.
98. Doenças Infecciosas: Conduta diagnóstica
e terapêutica. Schechter, M & Marangoni,
DV, editores. Editora Guanabara Koogan, Rio de Janeiro, Segunda
Edição, 1998.
99. Manual de HIV/AIDS. Rachid, M & Schechter,
M. Editora Revinter, Quarta Edição,
Rio de Janeiro, 1999.
100. Manual de HIV/AIDS. Rachid, M & Schechter,
M. Editora Revinter, Quinta Edição,
Rio de Janeiro, 2000.
101. Manual de HIV/AIDS. Rachid, M & Schechter,
M. Editora Revinter, Sexta Edição,
Rio de Janeiro, 2001.
102. Manual de HIV/AIDS. Rachid, M & Schechter,
M. Editora Revinter, Sétima Edição,
Rio de Janeiro, 2002.
103. Manual de HIV/AIDS. Rachid, M & Schechter,
M. Editora Revinter, Oitava Edição,
Rio de Janeiro, 2004.
CAPÍTULOS
DE LIVRO
104. Schechter, M. Diabetes e infecção.
In Diabetes Mellitus na pr†tica médica. Vaisman,
M & Tendrich M, Editores. Editora Cultura Médica,
Rio de Janeiro, 1994; 231-237.
105. Schechter, M. Diabetes Mellitus e Doenças
Infecciosas. In Diabetes Mellitus - Clínica, Diagnóstico
e Tratamento Multidisciplinar. Oliveira, P.E & Milech,
A, Editores. Editora Atheneu, São Paulo, 2004; 199-215.
PARTICIPAÇÕES
EM CONGRESSOS NO EXTERIOR
106. Chapman, M.D.; Snary, D.; Flint, J.E.; Schechter,
M.; Miles, M.A. (1983). Monoclonal antibodies which
define a 72K glycoprotein and tissue cross reacting antigens
in T. cruzi. Fifth International Congress of Immunology, Kyoto,
Japan.
107. Schechter, M.; Flint, J.E.;
Miels, M.A. (1984). Prospects for species and strain specific
diagnosis of T. cruzi infection. XI International Congress
for Tropical Medicine and Malaria, Calgary, Canada.
108. Stevens, A.F.; Schechter, M.; Chapman,
M.D.; Allen, A.K.; Miles, M.A. (1985). Quantitation of 72,000
molecular weight cell surface glycoprotein in Trypanosoma
cruzi zymodemes and detection of anti-GP72 antibodies in patients
carrying different zymodemes. Joint meeting between The British
Society of Immunology and The British Society for Allergy
and Clinical Immunology, London, UK.
109. Schechter, M. ; Valentine, F.T. (1989).
Differences in killing of CD4 cells induced by HIV isolates
from asymptomatic and AIDS patients, as measured by Cr51 release
assay. V International Conference on AIDS, Montreal, Canada.
110. Schechter, M.; May, S.B.; Bretas, G.;
Ramos-Filho, C.F.; Lima, L.A.A. (1990). A pre-evaluation of
a new, WHO- sponsored staging system for HIV infection. VI
International Conference on AIDS, San Francisco, USA.
111. Peixoto, M.A.C.; Caiuby, M.J.; Assis, T.L.; Schechter,
M. (1990). A higher than expected frequency of Histoplasmosis
: Importance of routine obtention of blood cultures for fungi.
VI International Conference on AIDS, San Francisco, USA.
112. Felix de Pinho, A.M.; Marangoni, D.V.; Moreira, M.B.;
Ramos-Filho, C.F.; Rodriguez, K.M.P.; Schechter, M.;
Paz, N.A. (1990). Possible high frequency of bacteriuria among
brazilian AIDS patients. VI International Conference on AIDS,
San Francisco, USA.
113. Sohler, M.P.; Correa, R.B.; Perez, M.A.; Schechter,
M.; Ramos-Filho, C.F.; Novis, S.A.P. (1990). Criteria
for presumptive diagnosis of neurotoxoplasmosis : Are they
adequate? VI International Conference on AIDS, San Francisco,
USA.
114. Sohler, M.P.; Correa, R.B.; Perez, M.A.; Schechter,
M.; Ramos-Filho, C. F.; Novis, S.A.P. (1990). Comparative
study of neurological complications in 172 cases of HIV infection.
VI International Conference on AIDS, San Francisco, USA.
115. Manela-Azulay, M.; Caneschi, J.R.T.; Cavalcanti, M.;
Ramos-Filho, C.F.; Perez, M.A.; Schechter, M.;
Pereira Jr., A.C.(1990). Dermatological findings in patients
with advanced HIV-related disease in Brazil. VI International
Conference on AIDS, San Francisco, USA.
116. Ramos-Filho, CF; Schechter, M. (1990).
Natural history of HIV infection in Brazil and other parts
of the world: A proposal for a comparative study. VII INCLEN,
Puebla, Mexico.
117. Cruz, MW; Sohler, MP; Correa, RB; Cavalcanti, M; Schechter,
M; Novis, SAP. (1991). VIII Congresso Pan-Americano
de Neurologia, Montevideo, Uruguai.
118. Sohler, M.P.; Correa, R.B.; Cavalcanti, M.; Schechter,
M.; Novis, S.A.P.(1991). Manifestations neurologiques
associees a l'infection par l'HTLV-1 chez une famille bresilienne.
Congres de Neurologie Tropicale, Limoges, França.
119. Correa, RB; Sohler, MP; Costa, MF; Zayen, E; Novis, SAP;
Schechter, M (1991). L'impact des manifestations
neurologiques sur la survie des patients bresiliens atteints
par le SIDA. Congres de Neurologie Tropicale, Limoges, França.
120. Cavalcanti, M.; Schechter, M.; Sohler,
M.; Leite, D.M.; Ferreira-Junior, O.C. (1991). Vertical and
horizontal transmission of HTLV-1 in 4 generations of a brazilian
family. VII International Conference on AIDS, Florenca, Itália.
121. Schechter, M.; Teixeira, M.L.B.; Carvalho,
A.C.C.; Peres, M. (1991). Predictors of pulmonary tuberculosis
in sputum-negative brazilian AIDS patients. VII International
Conference on AIDS, Florenca, Itália.
122. Schechter, M.; Sereno, A.B.; Espanha,
C.; Cerqueira, E.M.F.P. (1991). Predictors of fungemia in
AIDS patients: A case-control study. VII International Conference
on AIDS, Florenca, Itália.
123. Schechter, M; Leite, DM, Zajdenverg,
R; Machado, LL; Ramos-Filho, CF; Perez, MA. (1992).Predictors
of CD4 counts in HIV-infected Brazilian individuals. VIII
International Conference on AIDS, Amsterdam, Holanda.
124. Lima, LAA; May, SB; Ramos-Filho, CF; Perez, M; Schechter,
M. (1992). Survival of HIV-1 infected Brazilian individuals:
a model based on the WHO staging system VIII International
Conference on AIDS, Amsterdam, Holanda.
125. Pinho, A.M.F.; Schechter, M; Oliveira,
MPB; Halpern, M; Gouveia, CA; Ramos-Filho, CF. (1992). Urinary
Tract Infection Is More Common In AIDS Patients Than In Asymptomatic
HIV-infected Individuals, Or In Non-HIV Infected Patients.
VIII International Conference on AIDS, Amsterdam, Holanda.
126. Zajdenverg, R; Machado, LM; Valle, SOR; Silva, DRFF;
Souza, ACM; Baptista, AA; Perez, MA; Schechter, M.
(1992). PPD Reactivity and Risk of Development of Tuberculosis
in HIV Infected Brazilian Patients. VIII International Conference
on AIDS, Amsterdam, Holanda.
127. Werneck, EB; Carvalho, ACC; Kritski, A; Cavalcanti, M;
Santino MR; Schechter, M.; Qinn, T; Harrison,
L; Halsey, N. (1992). Prevalence of Retroviral Infections
in Intravenous Drug Users in Rio de Janeiro, Brazil. VIII
International Conference on AIDS, Amsterdam, Holanda.
128. Werneck, EB; Silva, SGC; Rodrigues, CA; Kritski, AL;
Ferreira, JA; Schechter, M; Galvao-Castro,
B. (1992). Measurement of false-positive rate in a screening
program for HIV-1 among 1398 patients with tuberculosis in
Rio de Janeiro, Brazil. VIII International Conference on AIDS,
Amsterdam, Holanda.
129. Cheingsong-Popov, R; Garasy, H; Callow, D; Bobkov, A;
Wasi, C;
Potrascu, R; Kalsebu, F; Van de Perre, P; Gurtler, L; Gilks,
C; Constantine, N; Schechter, M; Beddows,
S; Weber, J. (1992). Antigenic and genomic diversity of the
HIV-1 V# loop: Analysis of geographical variation by serology
, neutralization and sequencing. VIII International Conference
on AIDS, Amsterdam, Holanda.
130. Lacerda, MCR; Cardoso, SW; Perez, MA; Schechter,
M (1992). Private versus state medical care of AIDS
patients in Rio de Janeiro, Brasil: Impact on survival. VIII
International Conference on AIDS, Amsterdam, Holanda.
131. Collareda, N; Oliveira, RS; Schechter, M.
(1992). Parenteral behaviour and vertical transmission of
HIV-1 in Rio de Janeiro, Brasil. VIII International Conference
on AIDS, Amsterdam, Holanda.
132. Werneck, EB; Silva, SGC; Rodrigues, CA; Kritsky, A; Ferreira,
JA; Schechter, M; Galvao-Castro, B. (1992).
Measurement of false positive rate in a screening program
for HIV-1 among 1398 patients with tuberculosis in Rio de
Janeiro, Brasil. VIII International Conference on AIDS, Amsterdam,
Holanda.
133. Dines, I; Schechter, M; Leite, DM; Pinto,
ME; Persechini, PM. (1992). NK activity in HIV infected brazilian
individuals with different degrees of immune disfunction.
VIII International Conference on AIDS, Amsterdam, Holanda.
134. Schechter, M; Leite, DM, Zajdenverg,
R; Machado, LL; Ramos-Filho, CF; Perez, MA. (1992). Predictors
of CD4 counts in HIV-infected Brazilian individuals: A model
based on the WHO staging system. VII International Conference
on AIDS in Africa, Yaounde, República de Camaroes.
135. Durovni, B, Pinto, M; Schechter, M.
(1993). A prospective evaluation of 6 AIDS case definitions
in Rio de Janeiro, Brazil. IX International Conference on
AIDS, Berlin, Alemanha.
136. Schechter, M; Trade, G; Pinto, ME; Dines,
I; Quinn, TC; Halsey, NA; Harrison, LH. HIV-1 and HTLV-1 infection:
A case-control study. IX International Conference on AIDS,
Berlin, Alemanha.
137. Dines, I; Schechter, M; Silva, AT; Persechini,
PM. (1993) Clinical correlates of NK cell number and activity
in HIV positive patients. IX International Conference on AIDS,
Berlin, Alemanha.
138. May, SB; Perez, MA; Pinto, ME; Schechter, M;
Ramos-Filho, CF. (1993). High prevalence of HIV-1 infection
in a representative sample of childbearing women in Rio de
Janeiro, Brazil. IX International Conference on AIDS, Berlin,
Alemanha.
139. Pinto, ME; Carvalho, AP; Nogueira, C; Ferreira-J, O;
Schechter, M. (1993). Prevalence of antibodies
to Hepatitis C virus in populations at low and high risk for
sexually transmitted diseases in Rio de Janeiro. IX International
Conference on AIDS, Berlin, Alemanha.
140. Dines, I; Schechter, M; Silva, AT; Persechini,
PM. (1993). Natural Killer cell function and number in HIV-1
positive patients: CD16/56+ with CD3- or CD3+ phenotype. IX
International Conference on AIDS, Berlin, Alemanha.
141. Santos, MS; Guimaraes MDC; Schechter, M;
Boschi-Pinto,C; Castilho, E; Neves Jr, I. (1993). Prevalence
of HTLV infection among heterosexual couples with HIV positive
male index cases. (1993). IX International Conference on AIDS,
Berlin, Alemanha.
142. Schechter, M; Pinto, ME; Hofer, CB;
Zajdenverg, R. (1993). Correlates of p24 antigenemia in HIV-1
infected Brazilian individuals. IX International Conference
on AIDS, Berlin, Alemanha.
143. Pinto, ME; Cheingsong-Popov, R; Weber, J; Schechter,
M. (1993). Correlates of reactivity to V3 loop peptides
in HIV-1 infected patients in Rio de Janeiro, Brazil. IX International
Conference on AIDS, Berlin, Alemanha.
144. May, SB; Perez, MA; Schechter, M. (1993).
HIV-1 prevalence in 4536 childbearing women attending maternity
wards in Rio de Janeiro: A model based in correspondence analysis.
IX International Conference on AIDS, Berlin, Alemanha.
145. Harrison, LH; Schechter, M; Halsey,
NA; Moulton, LH; Quinn, TC. (1993). Coinfection with Human
T-cell Lymphotropic Virus Type I (HTLV-I) among adults with
HIV infection in Brazil. V B. Frank Polk Symposium, Baltimore,
EUA.
146. Cruz, MW; Correa, RB; Sohler, MP; Vaz, BP; Schechter,
M; Novis, SAP. (1993). ENMG and SSEP Study in HTLV-1
patients. XIII International Congress of Electroencephalography
and Clinical Neurophysiology. Vancouver, Canada.
147. Schechter, M; Trade, G; Pinto, ME; Dines,
I; Quinn, TC; Halsey, NA; Harrison, LH. HIV-1 and HTLV-1 dual
infection: Impact on CD4 counts and clinical stage. VII International
conference on AIDS in Africa.
148. Nucci, M; Schechter, M; Spector, N;
Pulcheri, W; Caiuby, MJ; Morais, JC; Maceira J; Carvalho,
DM; Oliveira, HP. (1993). Antibiotic regimen as an independent
risk factor for disseminated fungal infections in neutropenic
patients (Submetido). Trends in Invasive fungal infections
II, Manchester, Inglaterra.
149. Harrison, LH; Schechter, M; Halsey,
NA; Moulton LH; Quinn, TC. (1993). Ompact of co-infection
with HTLV-1 and HIV on markers of HIV disease progression.
I National Conference on Human Retroviruses and related infections.
Washington, EUA.
150. Janini, LM; Luo, C-C; Peralta, JM; Schechter,
M; Kalish, ML; Pieniazek, N; de La Torrre, N; Schochetman,
G; Rayfield, M; Pieniazek, D. (1994). Identification of three
distinct HIV-1 subtypes in Brazil based on the protease gene.
93rd general meeting, American Society for Microbiology, Las
Vegas, EUA.
151. Harrison, LH; Vaz, B; McArthur, JC; Schechter,
M. (1994). HTLV-1-related neurologic manifestations
among Brazilians subjects co-infected with HTLV-1 and HIV.
VIth International Conference on Human Retrovirology: HTLV,
New Jersey, EUA.
152. Murta F; Schechter, M; Zajdenverg, R;
Artemenko, S; Gay, V. (1994). Reasons for participating in
clinical trials in Brazil. X International Conference on AIDS,
Yokohama, Japão.
153. Costa, SM; Shindo, N; Vicente, ANP; Pinto, ME; Schechter,
M; Tanuri, A. (1994). Full sequence of GP120 of an
HIV-1 variant (GWGR) highly prevalent in Brazil. X International
Conference on AIDS, Yokohama, Japão.
154. Harrison, LH; Schechter, M; Vaz, BP;
McArthur, JC. (1994). HIV-1/HTLV-1 coinfection is associated
with a high frequency of myelopathies. X International Conference
on AIDS, Yokohama, Japão.
155. Schechter, M; Oliveira, E;, Pinto, ME;
Souza, VMA; Bronstein, M. (1994). Heat versus acid dissociation
of immune complexes for the detection of p24 antigenemia.
X International Conference on AIDS, Yokohama, Japão.
156. Nardelli, B; Gonzales, CJ; Schechter, M;
Valentine, FT. (1994). HIV-infected cells can kill CD4+ cells
upon contact. X International Conference on AIDS, Yokohama,
Japão.
157. Kritski, AL; Carvalho, ACC; Schechter, M;
Vieira, MAS; Oliveira, J; Werneck, EB; Ferreira, O; Novort,
N; Hearst, N. (1994). HIV-1, HTLV-1 and tuberculosis among
intravenous drug users in Rio de Janeiro, Brazil. X International
Conference on AIDS, Yokohama, Japão.
158. Janini, M; Pieniazek, D.; Luo, C-C.; DeLatorre, N.; Peralta,
J.M.; Schechter, M.; Tanuri, A.; Pieniazek,
N.; Schochetman, G.; Rayfield, M. (1995). Fluctuations in
culutre of distinct HIV-1 strains from dually infected persons.
II National Conference on Human Retroviruses and Related Infections,
Washington, USA.
159. Pieniazek, D.; Janini, M; ; Luo, C-C.; DeLatorre, N.;
Peralta, J.M.; Tanuri, A.; Schechter, M.;
Pieniazek, N.; Kalish, M.; Schochetman, G.; Rayfield, M. (1995).
Confirmation of homotypic dual infections with HIV-1 and phylogenetic
analyses of the contributing subtypes. II National Conference
on Human Retroviruses and Related Infections, Washington,
USA.
160. Harrison, L.H.; Schechter, M.; Vaz,
B.; MD. JC. Mcarthur (1995). Myelopathy Among Brazilians Coinfected
With Human T-Cell Lymphotropic Virus Type I and HIV. 35Th
Interscience Conference on Antimicrobial Agents and Chemotherapy,
San Francisco, USA.
161. Schechter. M.; Harrison. L.H.; Ronchini,
K.; Lederman, H.M. (1995) Immune dysfunction in HTLV-1 And
HIV Coinfection More Severe Than in HIV Infection Alone. 35Th
Interscience Conference on Antimicrobial Agents and Chemotherapy,San
Francisco, USA.
162. Harrison, L.H.; Schechter, M.; Vaz,
B.; MD. JC. Mcarthur (1995). Myelopathy Among Brazilians Coinfected
With Human T-Cell Lymphotropic Virus Type I and HIV. The VIIth
International Conference on Human Retrovirology, Paris, França.
163. Schechter. M.; Harrison. L.H.; Ronchini,
K.; T. C. Quinn; Lederman, H.M. (1995). Immune dysfunction
in HTLV-1 and HIV coinfection: Results of a pilot study. The
VIIth International Conference on Human Retrovirology, Paris,
França.
164. Rodrigues, L.G.M.; Larouze, B.; and the French-Brazilian
Research group on HTLV-1 (1995). HTLV I/II infection in Brazilian
adult patients with neurologic conditions. The VIIth International
Conference on Human Retrovirology, Paris, França.
165. Ramos, A.; Tanuri, A.; Janini, J.M.; Pinto, M.; Schechter,
M.; Peralta, M.; Bandea, C.; Schochetman, G.; Rayfield,
M.; Pieniazek, D. (1996). HIV-1 infections in Brazil: single,
duals and recombinants. 96th ASM General Meeting, New Orleans.
166. Respess, R.; Butcher, A.; Wang, H.; Chaowanachan, T.;
Young, N.; Shafer, N.; Mastro, T.; Biryahwaho, R.; Downing,
R.; Tanuri, A.; Schechter, M.; Pascy, R.;
Zekeng, L.; Kaptué, L.; Gurtler, L.; Ellenberg, C.;
Fridland, M.; Rayfield, M.; Kwok, S. (1996). Detection of
genetically diverse Human Immunodeficiency Virus Type I group
M and O isolates by PCR. 3rd. Conference on Retrovirus and
Opportunistic Infections, Washington, EUA.
167. Lyamya; E.F.; Schechter, M.; Echeveria
de Perez, G.; Vercauteren, G. (1996). Multicentre Evaluation
Of Alternative Methods For CD4 Lynphocyte Determination. XI
International Conference On AIDS, Vancouver, Canada.
168. Pinho, AMF; Lopes, GS; Lima, LAA; Schechter,
M. (1996). Incidence Of Tuberculosis In A cohort
of HIV-1 Infected Women In Rio de Janeiro, Brazil. XI International
Conference On AIDS, Vancouver, Canada.
169. Harrison, L.H.; Ferro, R.F.; Friedman, R.K.; Quinn, T.C.;
Rodrigues, J.; Schechter, M.. (1996). High
Prevalence of STDs and Hig-Risk Behavior Among Men Who Have
Sex With Men in an HIV Seroincidence Study In Brazil. XI International
Conference On AIDS, Vancouver, Canada.
170. Santos, E.M.; Lago, R.F.; Silva, S.B.; Costa, R.B.; Schechter,
M.; Harrison, L.H. (1996). Recruitment for an HIV
seroincidence study in Brazil: Alternative Approaches And
Lessons Learned. XI International Conference On AIDS, Vancouver,
Canada.
171. Lago, R. F.; Harrison, L.H.; Schechter, M.
(1996). Willingness Of Participants In An HIV Seroincidence
Study In Rio De Janeiro, Brazil To Participate In Future Vaccine
Trials. XI International Conference On AIDS, Vancouver, Canada.
172. Pinto, M.E.; Tanuri, A.; Schechter, M.
(1996). Frequency Of Subtypes Of HIV-1 in participants off
A cohort study in Rio de Janeiro, Brazil, as suggested by
endonuclease digestion patterns of the protease gene. 1996.
XI International Conference On AIDS, Vancouver, Canada.
173. Pinto, M.E.; Tanuri, A.; Schechter, M.
(1996). Differences in the prevalence of HIV-1 subtypes in
male and female participants of a cohort study in Rio de Janeiro,
Brazil. XI International Conference On AIDS, Vancouver, Canada.
174. Lopes, GS, Hofer, CB, Pinho, AMF, Schechter,
M. (1996). Natural history of HIV-1 infection in
women in Rio de Janeiro, Brazil. XI International Conference
On AIDS, Vancouver, Canada.
175. Lima, LAA; Neto PG; Pacheco, AGF; Faccio, MR; Neto, JS;
Moulton, LH; Schechter, M. (1996). Impact
of antiretroviral use on survival in a large brazilian seroprevalent
cohort. XI International Conference on AIDS, Vancouver, Canada.
176. Lewis-Ximenez, LL; Quinn, TC; Schatzmayer, H; Yoshida,
CT; Schechter, M. (1996). Quantitative detection
of Hepatitis C virus and Human Immunodeficiency Virus RNA
in Brazilian Coinfected Patients. XI International Conference
On AIDS, Vancouver, Canada.
177. Harrison, L.H; Quinn, T.C.; Schechter, M.(1996).
Human T-Cell Lymphotropic Virus Type I Does Not Increase HIV
Viral Load in Vivo. 36th ICAAC, New Orleans, EUA.
178. Janini, L.M.' Tanuri, A.; Schechter, M.;
Ramos, A.; Schochetman, G; Rayfield, M.; Pieniazek, D. (1997).
Horizontal and Vertical Transmission of HIV-1 Dual Infections
Caused by Viruses of Subtypes B and C. 4th Conference on Retroviruses
and Opportunistic Infections, Washington, EUA.
179. Schechter, M; Moulton, LH; Harrison,
LH. (1997). HIV viral load and CD4 lymphocyte counts in subjects
coinfected with HTLV-1 and HIV-1. 37th ICAAC, Toronto, Canada.
180.
Fortes, CQ; Chaves, IA; Nogueira, SA; Schechter, M.;
Peixoto, CAM; Garbes Neto, P.. Endocarditis Due to Corynebacterium
diphtheriae: Case Report. Fourth International Symposium on
Modern Concepts in Endocarditis and Cardiovascular Infections,
La Marive, Yverdon-les-Bains, Switzerland, 1997.
181. Pinto, ME; Tanuri, A; Schechter, M.
Molecular and epidemiologic evidence for the discontinuous
introduction of subtypes B and F into Rio de Janeiro, Brazil.
Fifth Conference on Retroviruses and Opportunistic Infections.
Chicago, USA, 1998.
182. Barroso, PF; Harrison, LH; Souza, YC; Bonfim, AS; Schechter,
M; Gupta, P.Impact of anti-retroviral therapy on
HIV-1 seminal viral load. Fifth Conference on Retroviruses
and Opportunistic Infections. Chicago, USA, 1998.
183. Friedmam, R.K; Rodrigues, J; Fraga, L.F; Melo, M.F; Oliveira,
L; Schechter, M; Harrison, H.L. (1998). Prevalence
of markers for sexually transmitted diseases in a male population
at high risk for HIV infection. 12th World AIDS Conference,
Genebra.
184. Schechter, M; Pinho, A.M.F; Lima, L.A.L;
Lopes, G.S. (1998). Risk factors for tuberculosis (TB) in
a cohort of HIV-infected patients in Rio de Janeiro, Brazil.
12th World AIDS Conference, Genebra.
185. Silva, S; Portella, J; Longo, P.H.P; Fernandes, N.N;
Lago, R.F; Souza, M.B; Schechter, M. (1998).
Unprotected oral sex among men who have sex with men (MSM).
12th World AIDS Conference, Genebra.
186. Barroso, P.F; Harrison, H.L; Bressan, C.S; Melo, M.F;
Gupta, P; Schechter, M. (1998). High correlation
between plasma and seminal HIV-1 viral load in antiretroviral-naive
Brazilian subjects. 12th World AIDS Conference, Genebra.
187. Longo, P; Silva, S.N; Schechter, M;
Harrison, L.H. (1998). Willingness to participate in a vaccine
preparatory study in Rio de Janeiro, Brazil. 12th World AIDS
Conference, Genebra.
188. Schechter, M; Lopes, G; Pinho, A.M.F;
Lima, L.A.A; Hofer, C.B; Harrison, L.H; Moulton, L.H. (1998).
Gender and progression of HIV-associated immunodeficiency.
12th World AIDS Conference, Genebra.
189. Barroso, P F; Gupta, P; Schechter, M;
Melo, MF; Souza, Y; Harrison, LH (1999). Seminal HIV-1 Viral
Load Is Reduced by Antiretroviral Therapy and Is Correlated
with Plasma HIV-1 Viral Load. Sixth Conference on Retroviruses
and Opportunistic Infections. Chicago, USA, 1999.
190. Harrison, LH; Do Lago, RF; Ismerio, T; Schechter,
M. A High-Incidence Homosexual Male Cohort for Vaccine
Trials in Brazil. Sixth Conference on Retroviruses and Opportunistic
Infections. Chicago, USA, 1999.
191. G.Santoro-Lopes, L.H. Harrison, M.D. Tavares, A Xexeo,
Schechter, M. V3- Binding Serotypes and HIV
Disease Progression in Brazil: Is B Different from B'?. 39th
Interscience Conference on Antimicrobial Agents and Chemotherapy.
San Francisco, Califórnia, USA. Setembro 26-29, 1999.
192. Schechter, M; R.F. Lago, R.I. Moreira,
H.W. Sheppard, L.H. Harrison. The Sensitive/Less Sensitive
HIV Testing Strategy to Identify a High-Risk Heterosexual
Population for HIV Vaccine Trials in Brazil. 39th Interscience
Conference on Antimicrobial Agents and Chemotherapy. San Francisco,
Califórnia, USA. Setembro 26-29, 1999.
193. L.H. Harrison, R.F. do Lago, R.I. Moreira, M.
Schechter. Demand for Post- Sexual-Exposure Chemophophylaxis
for the Prevention of HIV Infection in Brazil. 39th Interscience
Conference on Antimicrobial Agents and Chemotherapy. San Francisco,
Califórnia, USA. Setembro 26-29, 1999.
194. P.F. Barroso, M. Schechter, P. Gupta,
M.F. Melo, M.Vieira, F.C. Murta, C. Bressan, S. Bomfim , L.H.
Harrison. Seminal HIV-1 Shedding is Increased by the Presence
of Genital Warts. 39th Interscience Conference on Antimicrobial
Agents and Chemotherapy. San Francisco, Califórnia,
USA. Setembro 26-29, 1999.
195. P.F. Barroso, M. Schechter, P.Gupta,
M.F. Melo, M. Vieira, F.C. Murta, Y. Souza, L.H. Harrison.
Adherence to Antiretroviral Therapy (ART) is Associated with
Seminal Viral Load (SVL) Supression. 39th Interscience Conference
on Antimicrobial Agents and Chemotherapy. San Francisco, Califórnia,
USA. Setembro 26-29, 1999.
196. C.B. Hofer, Schechter, M, R.I. Moreira,
J.C. Struchiner, J. Rodrigues, R. Khalili, F. Melo, L.H. Harrison.
The absence of a definition of Acute Retroviral Syndrome (ARS)
in a Cohort of HIV-Seronegative Homosexual Men in Brazil.
39th Interscience Conference on Antimicrobial Agents and Chemotherapy.
San Francisco, Califórnia, USA. Setembro 26-29, 1999.
197. Barroso, PF; Schechter, M; Gupta, P;
Murta, FC; Vieira, M; Melo, MF; Souza, Y; Harrison, LH. Rebound
of Seminal HIV-1 Viral Load Associated with Sexually Transmitted
Diseases (STDs) after Virologic Suppression by Antiretroviral
Therapy. Seventh Conference on Retroviruses and Opportunistic
Infections, San Francisco, USA, 2000.
198. Barroso, PF; Harrison, LH; Gupta, P; Murta, FC; Souza,
Y; Melo, MF; Vieira, M; Schechter, M.Predictors
of Seminal Viral Load (SVL) Suppression in Subjects Starting
Antiretroviral Therapy (ART). Seventh Conference on Retroviruses
and Opportunistic Infections, San Francisco, USA, 2000.
199. Schechter, M; Lago, RF; Moreira, RI;
Sheppard, HW; Guimar_es, NC; Harrison, LH. Sensitive/Less-Sensitive
HIV Testing Strategy to Identify a High-Risk Heterosexual
Population in Brazil. Seventh Conference on Retroviruses and
Opportunistic Infections, San Francisco, USA, 2000.
200. Harrison, LH; Lago, RF; Moreira, RI; Schechter,
M. Demand for Post-Sexual-Exposure Chemoprophylaxis
for the Prevention of HIV Infection in Brazil. Seventh Conference
on Retroviruses and Opportunistic Infections, San Francisco,
USA, 2000.
201. Grinsztejn, B; Bastos, FI; Veloso, VG; Russomano, F;
Camargo, MJ; Silva, SM; Tarumano, E; Derrico, M; Schechter,
M. Risk factors for HPV infection in a cohort of
HIV-1 infected women with a high prevalence of co-infection
by oncogenic HPV. XIII International AIDS Conference, Durban,
África do Sul, 2000.
202. Schechter, M; Pinho, AMF; Lopes, GS;
Tavares, MD. Tuberculosis and survival of HIV-infected patients
in an area with a high prevalence of M. tuberculosis infection.
XIII International AIDS Conference, Durban, África
do Sul, 2000.
203. Fernandes, N; Schechter, M; Harrison,
L; Lago, R. Homosexuality and willingness to participate in
an HIV vaccine trial. XIII International AIDS Conference,
Durban, África do Sul, 2000.
204. Friedman, RK; Rodrigues, J; Fernandes, MN; Moreira, IR;
Schechter, M; Harrison, L. Acceptability
of Post-Sexual-Exposure Chemoprophylaxis for the Prevention
of HIV Infection in Brazil. XIII International AIDS Conference,
Durban, África do Sul, 2000.
205. Souza, M; Schechter, M; Lago, R; Friedman,
R; Harrison, L. Perception of risk and regular partnership
among MSM in Rio de Janeiro, Brazil. HPV. XIII International
AIDS Conference, Durban, África do Sul, 2000.
206. Santoro-Lopes, G; Pinho, AMF; Schechter, M..
Reduced Risk of Tuberculosis (TB) among Patients with HIV
Infection Treated with Highly Active Antiretroviral Therapy
(HAART). 40th Interscience Conference on Antimicrobial Agents
and Chemotherapy, Toronto, Canadá, 2000.
207. Harrison, LH; Lago, RF; Moreira, RI; Mendelsohn,AB; Schechter,
M. Post-Sexual-Exposure Chemoprophylaxis (PEP) for
HIV: A Prospective Cohort Study of Behavioral impact. Eigth
Conference on Retroviruses and Opportunistic Infections, Chicago,
USA, 2001.
208. Vibhagool, A; Cahn,P; Schechter, M.;
Soto-Ramirez, L ; Montroni, M; Smail, F; Thomas, N. Abacavir/Combivir
(ABC/COM) is Comparable to Indinavir/Combivir in HIV-1 Infected
Antiretroviral Therapy Naive Adults: Preliminary Results of
a 48-week Open Label Study (CNA3013). The 1st IAS Conference
on HIV Pathogenesis and Treatment, Buenos Aires, Argentina,
2001.
209. Schechter, M; Lago, R; Moreira, R; Mendelsohn,
A; Harrison, L. Behavioral Impact of The Availability of Post
Sexual Exposure Chemoprophylaxis (PEP) For HIV: A prospective
Cohort Study. The 1st IAS Conference on HIV Pathogenesis and
Treatment, Buenos Aires, Argentina, 2001.
210. Pinto, M; Schechter, M; Struchiner,
C; Russo, C. Evidence For Two Different Phylogenetic Distribution
Patterns of GWGR and GPGR Variants of Subtype B HIV-1 Viruses
in Brazil. The 1st IAS Conference on HIV Pathogenesis and
Treatment, Buenos Aires, Argentina, 2001.
211. Santoro-Lopes, G; Pinho, A; Harrison, L; Schechter,
M. Reduced Risk of Tuberculose (TB) Among Patients
With HIV Infection Treated with HAART in a Brazilian Cohort.
The 1st IAS Conference on HIV Pathogenesis and Treatment,
Buenos Aires, Argentina, 2001.
212. Schechter, M; Lago, RF; Ismerio, R;
Mendelsohn, AB; Harrison, LH. Acceptability, Behavioral Impact,
and Possible Efficacy of Post-Sexual-Exposure Chemoprophylaxis
(PEP) for HIV. Ninth Conference on Retroviruses and Opportunistic
Infections, Seattle, USA, 2002.
213. Coplan, P; Nikas, A; Kallas, E; Pitisuttithum, P; Schechter,
M; Puthavathana, P; Fu, TM; Dubey, S; Freed, D; Thaler,
S; Mehrotra, D; Condra, J; Emini, E; Shiver, J. Reactivity
of anti-HIV T-cell immune responses to different HIV-1 subtypes
among HIV+ individuals from Brazil, Thailand and the US. XIV
International AIDS Conference, Barcelona, Espanha, 2002.
214. Souza, M; Yoshida, C; Santos, G; Schechter, M;
Valente, O. Community participation on HIV vaccine research
in Brazil. XIV International AIDS Conference, Barcelona, Espanha,
2002.
215. Hofer, CB; Schechter, M; Harrison, LH.
Effectiveness of antiretrovirals in patients who attend HIV
clinics in Rio de Janeiro, Brazil. XIV International AIDS
Conference, Barcelona, Espanha, 2002.
216. Grinsztejn, BG; Bastos, FI; Veloso, VG; Russomano, F;
Morgado, M; Pilotto, JH; Friedman, RK; Taromaru, E; Derrico,
M; Schechter, M. High HPV viral loads associated
with advanced immunodeficiency and pre-invasive cervical lesions
in HIV infected women in Rio de Janeiro, Brazil. XIV International
AIDS Conference, Barcelona, Espanha, 2002.
217. Cook, RL; May, S; Harrison, LH; Ness, RB; Ismerio, R;
Schechter, M. High prevalence of HIV and
sexually transmitted infections among young women seeking
HIV testing in Rio de Janeiro. XIV International AIDS Conference,
Barcelona, Espanha, 2002.
218. Friedman, RK; Lourenço, MC; Veloso, VG; Grinsztejn,
B; Schechter, M; Bastos, FI. HIV-infected
marginalized and abused women from Rio de Janeiro, Brazil
are heavily coinfected with HPV but have low/moderate prevalences
for other sexually transmitted infections. XIV International
AIDS Conference, Barcelona, Espanha, 2002.
219. Varella, RB; Castro, MB; Ferreira, SB; Schechter,
M; Tavares, MD. Frequent presence of polymorphisms
in the protease and reverse transcriptase genes of viruses
obtained from treatment-naive Brazilian patients. XIV International
AIDS Conference, Barcelona, Espanha, 2002.
220. Barroso, PF; Schechter, M; Cerbino-Neto,
J; Almeida, MHH; Littleton, M; Harrison, LH. Sexual activity
after initiation of antiretroviral therapy in Brazil. XIV
International AIDS Conference, Barcelona, Espanha, 2002.
221. Leth, FV; Phanuphak, P; Gazzard, B; Chan, P; Wood, R;
Bloch, M; Katlama, C; Schechter, M; Murphy,
R; Horban, A; Hall, D; Van der Valk, M; Lange, J; Reiss, P.
Lipid Changes in a Randomized Comparative Trial of First-line
Antiretroviral Therapy with Regimens Containing Either Nevirapine
Alone, Efavirenz Alone or Both Drugs Combined, Together with
Stavudine and Lamivudine (2NN Study). 10th Conference on Retroviruses
and Opportunistic Infections, Boston, Massachusetts, USA,
2003.
222. Lima, LA; Schechter, M; Jenkins, FJ;
Moore, PS; Renwick, NM; Harrison, LH. Risk Factors for Kaposi's
Sarcoma-associated Herpesvirus Infection among Homosexual
Men at Hight Risk for HIV Infection in Brazil. 10th Conference
on Retroviruses and Opportunistic Infections, Boston, Massachusetts,
USA, 2003.
223. Barroso, PF; Schechter, M; Cerbino-Neto,
J; Almeida, MHH; Harrison, LH. Safer Sex After Initiation
of Antiretroviral Therapy in a Public HIV Clinic in Brazil.
10th Conference on Retroviruses and Opportunistic Infections,
Boston, Massachusetts, USA, 2003.
224. Cook, R; May, S; Harrison, LH; Ismerio, R; Ness, R, Schechter,
M. Risk Factors for HIV and STDs among Young Women
Seeking HIV Testing in Rio de Janeiro. 10th Conference on
Retroviruses and Opportunistic Infections, Boston, Massachusetts,
USA, 2003.
225. Tavares, MD; Varella, RB; Ferreira, SB; de Castro, MB;
Malta, FC; Schechter, M. Large Scale use
of Antiretroviral Drugs is not Associated with a High Prevalence
of Genotypic Resistance Mutations in Treatment-Naive HIV-1
Infected Individuals in Rio de Janeiro, Brazil.The 2nd IAS
Conference on HIV Pathogenesis and Treatment, Paris, France,
2003.
226. Pinto, ME; Schechter, M; Struchiner,
C; Miranda, AB; Russo, CAM. Is Natural Selection Involved
in the Rapid Expansion of GWGR Subtype B Variant in Brazil?
The 2nd IAS Conference on HIV Pathogenesis and Treatment,
Paris, France, 2003.
227. Barroso, PF; Harrison, LH; Melo, MF; Batista, S; Bastos,
M; Faulhaber, J; Moreira, RI; Lago, RF; Schechter,
M. Identification of a High-Risk Heterosexual Cohort
for HIV Vaccine Efficacy Trials in Rio de Janeiro, Brazil.
The 2nd IAS Conference on HIV Pathogenesis and Treatment,
Paris, France, 2003.
228. May, SB; Cook, RL; Harrison, LH; Ness, RB; IsmÇrio,
R; Batista, S; Schechter, M. HIV and STI
Interactions Among Young Women Seeking HIV Testing in Rio
de Janeiro. The 2nd IAS Conference on HIV Pathogenesis and
Treatment, Paris, France, 2003.
229. Mast, TC; Gupta, S; Nikas, A; Kierstead, L; Kallas, EG;
Mbewe, B; Pitisuttithum, P; Schechter, M;
Vardas, E; Wolfe, N; Coplan, P; Aste-Amezaga, M; Shiver, J;
Emini, EA; Straus, WL. International Epidemiology Human Pre-existing
Anti-Adenovirus Type-5 (Ad5) Neutralizing Antibodies in Areas
Representative of Potential HIV Vaccine Trial Sites. AIDS
Vaccine 2003, New York, USA, 2003.
230. Jack, N; Schechter, M; Pape, J; Sanchez,
J; Jean, S; Lago, RF; Metch, B; Hansen, M; Harrison, L; Sanchez,
J; Cleghorn, F; Wright, P; Bartholomew, C. Conduct of a Mmulti-site
HIV Vaccine Trial (HIVNET026) in the Caribbean and South America.
AIDS Vaccine 2003, New York, USA, 2003.
231. Barroso, PF; Harrison, LH; Telles, S; Silva, SB; Nunes,
EP; Almeida, MMT; Moreira, RI; Lago, RF; Schechter,
M; Projeto Praáa Onze. Recruitment of a High-risk
Heterosexual Cohort for HIV Vaccine Efficacy Trials in Rio
de Janeiro, Brazil. AIDS Vaccine 2003, New York, USA, 2003.
232. Gupta, S; Nikas, A; Freed, D; Kallas, E; Schechter,
M; Pitisuttithum, P; Vardas, E; Mbewe, B; Coplan,
P; Mast, T; Kublin, J; Guess, H; Straus, W. Feasibility of
Multiside International Epidemiologic Studies in Preparation
of Large Scale HIV Vaccine Efficacy Trials. AIDS Vaccine 2003,
New York, USA, 2003.
233. Schechter, M. HIV post-sexual exposure
prophylaxis. Int J Infect Dis, Suppl 1, 2004:S237. 11th International
Congress on Infectious Diseases. Cancun, México, 2004.
234. Hofer, CB; Schechter, M; Harrison, LH.
Morisky questions as a tool to evaluate adherence to antiretroviral
therapy in public primary care clinics in Rio de Janeiro,
Brazil. XV International AIDS Conference, Bangkok, Tailândia,
2004.
235. Souza, MB; Schechter, M; Yoshida, CB;
Pedrosa, J; Santos, GRS; Weinstein, A. Involving community
members in HIV vaccine research programs. XV International
AIDS Conference, Bangkok, Tailândia, 2004.
236. Barroso, PF; Vergara, TRC; Schechter, M;
Suarez-Kurtz, G; Estrela, RCE; Cerbino-Neto, J. Poor penetration
of lopinavir in the genital tract of men receiving HAART in
Brazil. XV International AIDS Conference, Bangkok, Tailândia,
2004.
237. Barroso, PF; Vettore, MV; Schechter, M;
Melo, MF; Boechat, LJ. Genital HIV-1 viral load is correlated
with blood plasma HIV-1 viral load in Brazilian women and
is reduced by antiretroviral therapy XV International AIDS
Conference, Bangkok, Tailândia, 2004.
238. Hofer, CB; Schechter, M; Harrison, LH.
Factors associated with antiretroviral adherence in public
clinics in Rio de Janeiro, Brazil. XV International AIDS Conference,
Bangkok, Tailândia, 2004.
239. Mast, TC; Gupta, S; Nikas, A; Kierstead, L; Burke, D;
Kallas, E; Novitsky, V; Mbewe, B; Pitisuttithum, P; Schechter,
M; Vardas, E; Aste-Amezaga, M; Shiver, J; Emini,
E; Straus. W. International epidemiology of human pre-existing
anti-adenovirus Type-5 (Ad5) neutralizing antibodies in areas
representative of potential HIV vaccine trial sites. XV International
AIDS Conference, Bangkok, Tailândia, 2004.
240. Gupta, SB; Freed, DC; Schechter, M;
Vardas, E; Kallas, E; Pitisuttithum, P; Mbewe, B; Kublin,
J; Mpoudi-Ngole, E.; Novitsky, V; Nikas, A; Mast, TC; Coplan,
P; Straus, W .Retention of subjects in a multi-site international
epidemiology study In preparation of large scale HIV vaccine
efficacy trials. XV International AIDS Conference, Bangkok,
Tailândia, 2004.
241. Barroso, PF; Teles, S; Silva, SB; Melo, MF; Nunes, EP;
Almeida, MMT; Fernandes, M; Lago, RF; Harrison, LH; Schechter,
M. Recruitment of a high-risk heterosexual cohort
for HIV vaccine efficacy trials in Rio de Janeiro, Brazil:
Risk profile and willingness to participate in vaccine trials.
XV International AIDS Conference, Bangkok, Tailândia,
2004.
242. Dabis F; Schneider M; Schechter, M;
Egger M. Characteristics of ART treatment programmes in low-income
countries: the ART-LINC collaboration. XV International AIDS
Conference, Bangkok, Tailândia, 2004.
243. Barroso PF, Telles S, Silva SB, Nunes EP, Almeida MMT,
Lago RF, Harrison LH, Schechter, M. Recruitment
and retention of a high-risk heterosexual cohort for HIV vaccine
efficacy trials in Rio de Janeiro, Brazil: risk profile and
willingness to participate in vaccine trials. AIDS Vaccine
2004 International Conference, Lausanne, Suíça,
2004.
244. Dabis, F; Schechter, M; Egger, M. Response
to Highly Active Retroviral Therapy in Low- and High-income
Countries: Analysis of Clinical Databases from 4 Continents.
12th Conference on Retroviruses and Opportunistic Infections,
Boston, Massachusetts, USA, 2005.
245. Tuboi, S; Sprinz, E; Harrison, LH; Albernaz, R; Schechter,
M. Predictors of Virological Failure at 6 Months
of Therapy in HIV-1-infected Patients Starting HAART in Porto
Alegre, Brazil. 12th Conference on Retroviruses and Opportunistic
Infections, Boston, Massachusetts, USA, 2005.
PARTICIPAÇÕES
EM CONGRESSOS NO BRASIL
246. Senna, M.; Murta, A.C.; Schechter, M.;
Miles, M.A.; Peralta, J.M.; Mendonca-Previato, L.; Scharfstein,
J. (1985). GP25 antigen of Trypanosoma cruzi: Identification
of a 60 Kd precursor with monoclonal antibodies. X Congresso
Brasileiro de Imunologia, Guarujá, Brasil.
247. Leme, V.M.C.; Murta, A.C.M.; Schechter, M.;
Miles, M.A.; Mendonca-Previato, L.; Scharfstein, J. (1985).
Characterization of a cross-reactive antigen of T. cruzi defined
with Sleeping Sickness sera. X Congresso Brasileiro de Imunologia,
Guarujá, Brasil.
248. Murta, A.C.M.; Leme, V.M.C.; Mendonca-Previato, L.; Schechter,
M.; Miles,M.A.; Scharfstein, J. (1985). Involvement
of carbohydrate structures in the antigenicity of T. cruzi
glycoproteins GP25 and GP 50/55. XIV Reunião Anual
da Sociedade Brasileira de Bioquimica, Caxambu, Brasil.
249. Leme, V.M.C.; Vieira, E.; Schechter, M.;
Miles, M.A.; Van Meirvene, N.; Mendonca-Previato, L.; Scharfstein,
J. (1985). Identification of T. cruzi glycoprotein GP 50/55
as a cross-reactive antigen of Trypanosomatids. XII Reuniao
Anual de Pesquisa Básica em Doença de Chagas,
Caxambu, Brasil.
250. Schechter, M.; Nogueira, N.; Cross,
G.A.M. (1987). Descriptive analysis of Trypanosoma cruzi surface
antigen profile: variations induced by different methodologies.
XIV Reunião Anual de Pesquisa Básica em Doença
de Chagas, Caxambu, Brasil.
251. Tendrich, M.; Feijo, P.; Monteiro, C.B.; Schechter,
M.; Man, M.(1989). Associacao de Diabetes Insipidus
central e AIDS. V Simposio Internacional de Neuroendocrinologia,
São Paulo, Brasil.
252. Manela-Azulay, M.; Caneschi, J.R.T.; Cavalcanti, M.;
Ramos-Filho, C.F.; Perez, M.A.; Schechter, M.;
Pereira Jr., A.C. (1990). Achados dermatológicos nos
pacientes com doença relacionada ao HIV em estágios
Avançados no Brasil. XIII Reunião Anual dos
Dermatólogos Latino-Americanos do Cone Sul, Rio de
Janeiro, Brasil.
253. Rodrigues, K.M.; Castineiras, T.M.P.P.; Santos, M.S.;
Pereira, M.T.; Papi A.; D'avila, C.; Duarte, F.; Schechter,
M.; Novis, S. (1990). AIDS e Miopatia. 140 congresso
Brasileiro de Neurologia, Rio de Janeiro, Brasil.
254. Sohler, M.P.; Correa, R.B.; Perez, M.A.; Schechter,
M.; Ramos-Filho, C.F.; Novis, S.A.P. (1990). Critérios
para o diagnóstico de neurotoxoplasmose: Serão
adequados ? Revisão de 80 casos. 140 congresso Brasileiro
de Neurologia, Rio de Janeiro, Brasil.
255. Sohler, M.P.; Correa, R.B.; Perez, M.A.; Schechter,
M.; Ramos-Filho, C.F.; Novis, S.A.P. (1990). Complicações
Neurologicas da SIDA/AIDSExperiencia do HUCFF-UFRJ. 140 congresso
Brasileiro de Neurologia, Rio de Janeiro, Brasil.
256. May, S.B.; Ramos-Filho, C.F.; Castilho, E.A.; Landman,
C.; Pinto, M.E.; Schechter, M. (1991). Soroprevalência
de HIV-1 nas pueperas do Rio de Janeiro: resultados preliminares.
VI Congresso Brasileiro de Infectologia, Salvador, Bahia,
Brasil.
257. Cruz, M. W.; Sohler, M. P.; Correa, R. B.; Cavalcanti,
M.; Schechter, M.; Novis, S. (1991). Alterações
eletroneuromiográficas associadas a infecção
pelo HTLV-1 numa familia brasileira. XII Congresso Brasileiro
de Eletroencefalografia e Neurofisiologia Clínica,
Gramado, Rio Grande do Sul.
258. Cruz, M. W.; Sohler, M. P.; Correa, R. B.; Cavalcanti,
M.; Schechter, M.; Novis, S. (1991). Estudo
eletroneuromiográfico em 10 pacientes com mielopatia
associada ao HTLV-1. XII Congresso Brasileiro de Eletroencefalografia
e Neurofisiologia Clínica, Gramado, Rio Grande do Sul.
259. Andrade, V.L.; Avelleira, J.C.; Marques, A.; Vxianna,
F.R.; Schechter, M. (1991). Lepra como causa
de resultados falso-positivos em testes sorológicos
para detecção de anticorpos anti-HIV. Congresso
Brasileiro de Dermatologia, Belo-Horizonte, Minas Gerais.
260. Cavalcanti, M.; Schechter, M.; Sohler,
M.; Leite, D.M.; Ferreira-Junior, O.C. (1991). Transmissão
vertical e horizontal de HTLV-1 em 4 gerações
de uma família. VI Reunião Anual da FESBE, Caxambu,
Minas Gerais.
261.
Schechter, M: Leite, DM; Zajdenverg, R; Machado,LL;
Ramos, CF; Perez, MA. (1992). Predição de contagem
de CD4 nos indivíduos infectados pelo HIV. III Congresso
de Infectologia dos países de lingua portuguesa, I
Congresso de Infectologia do Mercosul, São Paulo, SP.
262. Edelenyi, MP; Carvalho, AP; Artemenko, S; Ferreira Jr,
OC; Nogueira, C; Schechter, M. (1992). Prevalência
de anticorpos para o vírus da Hepatite C em populações
de baixo e alto risco para doenças de transmissão
sexual. III Congresso de Infectologia dos países de
lingua portuguesa, I Congresso de Infectologia do Mercosul,
São Paulo, SP.
263. Schechter, M; Trade, GCS; Santa-Rosa,
AAP (1992). Impacto da infecção pelo HTLV-1
em pacientes infectados pelo HIV-1. III Congresso de Infectologia
dos países de lingua portuguesa, I Congresso de Infectologia
do Mercosul, São Paulo, SP.
264. Lacerda, MCR; Cardoso, SW; Perez, MA; Schechter,
M (1992). Atendimento público X Atendimento
privado: Impacto na sobrevida de pacientes com AIDS. III Congresso
de Infectologia dos países de lingua portuguesa, I
Congresso de Infectologia do Mercosul, São Paulo, SP.
265. Carvalho, ACC; Kritski, AL; Bertoche, GLM; Costa, PA;
Pessoa, CLC; Orfalis, CS; Lucharewsky, BR; Werneck, EB; Schechter,
M; Andrade, GN (1992). Tuberculose infecção
e doença entre comunicantes de paciente com tuberculose
pulmonar e infecção pelo HIV. Estudo prospectivo:
Resultados preliminares. XXVI Congresso Brasileiro de Pneumologia
e Tisiologia, Jornal de Pneumologia 1992, 18 (2):109.
266. Correa, RB; Sohler, MP; Vaz, BP; Schechter, M;
Novis, SAP (1992). Mielopatia associada a infecção
por HTLV-1: Experiência do HUCFF-UFRJ. XV Congresso
Brasileiro de Neurologia, Porto Alegre, RS.
267. Hofer, CB; Pinto, ME; Zajdenverg, R; Schechter,
M (1993). A frequência de antigenemia e sua
correlação com critérios evolutivos na
infecção pelo HIV no Brasil. XXIX Congresso
da Sociedade Brasileira de Medicina Tropical, Fortaleza, Ceará.
268. Oliveira, RHS; Collareda, NL; Frota, AC, Schechter,
M. (1993). Aleitamento e transmissão vertical
do HIV-1. XXVIII Congresso Brasileiro de Pediatria, Salvador,
Bahia.
269. Schechter, M; Pinto, ME; Hofer, CB;
Zajdenverg, R. (1993). Correlates of p24 antigenemia in HIV-1
infected Brazilian individuals. XVIII Congresso Brasileiro
de Imunologia.
270. Pinto, ME; Carvalho, AP; Nogueira, C; Ferreira-J, O;
Schechter M. (1993). Prevalence of antibodies
to Hepatitis C virus in populations at low and high risk for
sexually transmitted diseases in Rio de Janeiro. XVIII Congresso
Brasileiro de Imunologia.
271. Dines, I; Schechter, M; Silva, AT; Persechini,
PM. (1993). Natural Killer cell function and number in HIV-1
positive patients: CD16/56+ with CD3- or CD3+ phenotype. XVIII
Congresso Brasileiro de Imunologia.
272. Dines, I; Schechter, M; Silva, AT; Persechini,
PM. (1993) Clinical correlates of NK cell number and activity
in HIV positive patients. XVIII Congresso Brasileiro de Imunologia.
273. Cruz, M. W.; Sohler, M. P.; Correa, R. B.; Cavalcanti,
M.; Schechter, M.; Novis, S. (1993). Eletroneuromiografia
e potenciais evocados somato-sensitivos em pacientes com mielopatia
associada ao HTLV-1. IX Jornada Brasileira de doenças
neuromusculares, São José do Rio Preto, São
Paulo.
274. Collareda, NL; Frota, AC; Silva-Oliveira, RH; Schechter,
M. (1993). Aleitamento Materno e transmissão
vertical do HIV-1. XXVIII Congresso Brasileiro de Pediatria,
Salvador, Bahia.
275. Nucci, M; Schechter, M; Spector, N;
Pulcheri, W; Caiuby, MJ; Morais, JC; Maceira J; Carvalho,
DM; Oliveira, HP (1993). Fatores de risco para infecções
fúngicas disseminadas em pacientes neutropênicos:
Estudo caso-controle. XIV Congresso Nacional do ColÇgio
Brasileiro de Hematologia, VI Simp¢sio Brasileiro de
Transplante de Medula óssea, III Encontro Nacional
de Enfermagem em transplante de medula óssea e hematologia,
III Simpósio Latino Americano de Hemafereses, Curitiba,
Paraná.
276. Torres, S; Schechter, M; Basilio, CA;
Cortezzi, W (1995). Infecção pelo vírus
Herpes Simples resistente ao aciclovir. III Congresso e XXI
Jornada Brasileira de Estomatologia, Gramado, Rio Grande do
Sul.
277. Pinto, ME; Goes Fo, Ramos CAB; Janini, LM; Pieniazek,
D; Rayfiled, MA; Schechter, M; Tanuri, A.
(1995). Genetic variation in protease gene of HIV-1 in Rio
de Janeiro. XXIV reunião anual da Sociedade Brasileira
de Bioquímica.
278. Schechter, M; Harrison L.H.; Ronchini,
K; Lederman, H.M. (1995). In Vivo T-Cell Dysfunction in Coinfection
With Human T-Cell Lymphotropic Virus Type I (HTLV-I) and HIV.
I Simpósio Brasileiro de Pesquisa Básica em
HIV/AIDS, Angra dos Reis, Rio de Janeiro.
279. Filho, T.G.J.; Pinto, M.E.; Costa J.L; Brigadeiro M.R.;
Vicente, C.A.; Pieniazek, D.; Rayfield A.M.; Schechter,
M.; Tanuri, A.(1995). Characterization of HIV-I Dual
Infection in Patients of Rio de Janeiro. I Simpósio
Brasileiro de Pesquisa Básica em HIV/AIDS, Angra dos
Reis, Rio de Janeiro.
280. Pinto M.E.; Tanuri, A.; Schechter, M.
(1995).Frequency of Subtypes of HIV-1 in Participants of a
Cohort Study in Rio de Janeiro as Suggested by Endonuclease
Digestion Patterns of The Protease Gene. I Simpósio
Brasileiro de Pesquisa Básica em HIV/AIDS, Angra dos
Reis, Rio de Janeiro.
281. Pinto M.E.; Tanuri, A.; Schechter, M.
(1995). Differences in The Prevalence of HIV-1 Subtypes in
Male and Female Participants of a Cohort Study in Rio de Janeiro.
I Simpósio Brasileiro de Pesquisa Básica em
HIV/AIDS, Angra dos Reis, Rio de Janeiro.
282. Vaz, B.; Schechter, M.; Harrison, L.H.;
McArthur, J.C. (1995). Myelopathy Among Brazilians Coinfected
With Human T-Cell Lymphotropic Virus Type I And HIV. I Simpósio
Brasileiro de Pesquisa Básica em HIV/AIDS, Angra dos
Reis, Rio de Janeiro.
283. Schechter, M.; Quinn, TC; Harrison,
LH. (1996). Coinfecá_o por HTLV-1 N_o Aumenta a Carga
Viral de HIV In Vivo.. IX Congresso Brasileiro de Infectologia.
Recife, PE.
284. Pinho, AMF, Lopes, GS, Lima LAA, Schechter, M.(1996)
Incidência de Tuberculose (TB) Em Uma Coorte de Mulheres
No Rio de Janeiro. IX Congresso Brasileiro de Infectologia.
Recife, PE.
285. Pinho, ME, Tanuri, A. Schechter, M.(1996).
Diferenças Na Prevalência de Subtipos de HIV-1
Entre Homens e Mulheres Participantes de Um Estudo de Coorte
No Rio de Janeiro. IX Congresso Brasileiro de Infectologia.
Recife, PE.
286. Lima, LAA, Netto, PG, Pacheco, AGF, Faccio, MR, Neto,
JC, Moulton, L, Schechter, M.(1996). Impacto
do Uso de Anti-Retroviral na Sobrevida em Uma Coorte de Pacientes
Infectados Pelo HIV. IX Congresso Brasileiro de Infectologia.
Recife, PE.
287. Lopes, GS, Hofer, CB, Pinho, AMF, Lima, LAA, Schechter,
M. (1996).Infecção Por HIV em Mulheres:
Análise Descritiva de Uma Coorte no Rio de Janeiro.
IX Congresso Brasileiro de Infectologia. Recife, PE.
288. VA, BP, Harrison, LH, Taveira, DM, Quinn, TC, Souda,
SH, McArthur, JC, Schechter, M.(1996). Manifestações
Neurológicas Associadas à Coinfecção
HIV/HTLV-1. IX Congresso Brasileiro de Infectologia. Recife,
PE.
289. Khalili, R, Rodrigues, J, Melo, MF, Harrison, LH, Schechter,
M.(1996). Prevalência de Marcadores de Doenças
Sexualmente Transmissíveis em Uma População
Masculina de Alto Risco Para a Infecção Pelo
HIV.IX Congresso Brasileiro de Infectologia. Recife, PE.
290. Lewis-Ximenez, LL, Quinn, TC, Schatzmayer, H. Yoshida,
CT, Schechter, M.(1996). Quantificação
da Carga Viral de HCV e de HIV em Pacientes Coinfectados por
Ambos os Vírus. IX Congresso Brasileiro de Infectologia.
Recife, PE.
291. Melo, MF, Godomiczer, A., Schmaltz, CAT, Harrison, LH,
Schechter, M. (1996). Validação
de Um Teste Rápido Para o Diagn¢stico Sorológico
em uma População Masculina de Alto Risco para
a Infecção Pelo HIV. IX Congresso Brasileiro
de Infectologia. Recife, PE.
292. Lopes, GS; Pinho, AMF; Lima, LAA; Hofer, CB; Harrison,
LH; Moulton, L; Schechter, M. Sobrevida após
SIDA: Estudo Comparativo entre sexos. VII Congresso PanamericanoX
Congresso Brasileiro de Infectologia, 18 a 23 de Maio, Salvador,
Bahia, 1997.
293. Pinho, AMF; Lopes, GS; Lima, LAA; Schechter,
M. Incidência de tuberculose em uma coorte
de pacientes com infecção pelo vírus
da imunodeficiência humana. VII Congresso PanamericanoX
Congresso Brasileiro de Infectologia, 18 a 23 de Maio, Salvador,
Bahia, 1997.
294. Dines, I; Harrison, LH; Lira, MCS; Barroso, PF; Schechter,
M. Ausência de associação entre
o sistema de estágios da OMS e carga viral do vírus
da imunodeficiência humana (HIV). VII Congresso Panamericano
X Congresso Brasileiro de Infectologia, 18 a 23 de Maio, Salvador,
Bahia, 1997.
295. Pinto, ME; Schechter, M; Tanuri, A.
Análise do polimorfismo do gene da protease do HIV-1
em amostras do Rio de Janeiro. II Simpósio Brasileiro
de Pesquisa Básica em HIV/AIDS, 07 a 11 de Setembro
de 1997, Angra dos Reis, RJ.
296. Melo, MF; Rosa-Santos, OL; Schmaltz, CAE; Godomicz, A;
Marinho, FM; Barros, ACM; Cunha, JMT; Silva, AG; Pinto, ME;
Schechter, M.. Soroprevalência do Herpes
simplex virus em doadores de sangue e em uma população
masculina de alto risco para a infecção pelo
HIV. II Simpósio Brasileiro de Pesquisa Básica
em HIV/AIDS, 07 a 11 de Setembro de 1997, Angra dos Reis,
RJ.
297. Lopes, G.S.; Schechter, M.; Santos,
ACE; Xexeo, Tavares, M.D,; Harrison, L. Sorotipo da Infecção
pelo HIV no Rio de Janeiro. XI Congresso Brasileiro de Infectologia,
01 a 04 de Agosto de 1999, Palácio das Convenções,
Anhembi, São Paulo, Brasil.
298. Lopes, G.S.; Lederman, H.M.; Schechter, M.;
Ronchini, K.; Harrison, L.; Pereira, E.M.M. Estudo da Resposta
Imune na Coinfecção HTLV-I/HIV.XI Congresso
Brasileiro de Infectologia, 01 a 04 de Agosto de 1999, Palácio
das Convenções, Anhembi, São Paulo, Brasil.
299. Pinto, M.E.; Schechter, M.; Struchiner,
C.J.; Russo, C.A.M. Evidência Molecular de Padrnoes
Distintos de Distribuição para os Variantes
GWGR e GPGR do Subtipo B de HIV-1 Encontrados no Brasil. V
Congresso Brasileiro de Epidemilogia - Epi 2002, 23 a 27 de
Março de 2002, Curitiba, Paraná, Brasil.
ORIENTAÇÃO
DE TESES
300. Luiz Antonio Alves de Lima - Tese de Mestrado, Departamento
de Medicina Preventiva, Faculdade de Medicina, UFRJ, 1992,
intitulada " Validação do Sistema de estágios
da Organização Mundial da Saúde para
infecção pelo HIV em adolescentes e adultos".
301. Marta Cavalcanti - Tese de Mestrado, Departamento de
Medicina Preventiva, Faculdade de Medicina, UFRJ, 1992, intitulada
"Estudo da ocorrência de infecção
pelo HTLV 1 em quatro gerações de uma família
brasileira e revisão da literatura".
302. Amâncio Paulino de Carvalho - Tese de Mestrado,
Departamento de Medicina Preventiva, Faculdade de Medicina,
UFRJ, 1992, intitulada "Transmissão sexual do
Vírus da Hepatite C".
303. Ana Maria Felix de Pinho - Tese de Mestrado, Departamento
de Medicina Preventiva, Faculdade de Medicina, UFRJ, 1992,
intitulada "Bacteriúria em pacientes infectados
pelo HIV".
304. Marcio Luiz Moore Nucci - Tese de Doutorado, Departamento
de Medicina Preventiva, Faculdade de Medicina, UFRJ, 1993,
intitulada "Fatores de risco para infecções
fúngicas disseminadas em pacientes neutropênicos
- Estudo caso-controle".
305. Beatriz Pereira Vaz - Tese de Mestrado, Departamento
de Clínica Médica, Faculdade de Medicina, UFRJ,
1996, intitulada "Mielopatia associada à co-infecção
pelo HTLV-1 e HIV".
306. Monica Edelenyi Pinto - Tese de Mestrado, Instituto de
Biofísica Carlos Chagas Filho, UFRJ, 1997, Intitulada
"Análise do polimorfisno de restrição
do gen da protease do HIV em amostras do Rio de Janeiro.
307. Rosângela Maria de Castro Cunha - Tese de Mestrado,Departamento
de Medicina Preventiva, Faculdade de Medicina, UFRJ, 1997,
intitulada "Soroepidemiologia da Rubéola em mulheres
puérperas atendidas pelo Sistema único de Saúde
em Juiz de Fora, Minas Gerais".
308. Guilherme Santoro Lopes - Tese de Doutorado, Departamento
de Medicina Preventiva, Faculdade de Medicina, UFRJ, 1998,
intitulada "Prognóstico da infecção
pelo HIV na cidade do Rio de Janeiro. Estudo comparativo entre
os sexos".
309. Henrique Sérgio de Morais Coelho, Tese de Doutorado,
Departamento de Medicina Preventiva, Faculdade de Medicina,
UFRJ, 1998, intitulada "Detecção de anticorpos
contra o vírus da Hepatite C na prevenção
da infecção pós-transfusional pelo vírus
da Hepatite C.
310. Cristina Barroso Hofer, Tese de Mestrado, Departamento
de Medicina Preventiva, Faculdade de Medicina, UFRJ, 1998,
intitulada "Descrição da síndrome
retroviral aguda em homens que relatam fazer sexo com homens,
no Rio de Janeiro."
311. Marisa Dias Tavares, Tese de Doutorado, Departamento
de Medicina Preventiva, Faculdade de Medicina, UFRJ, 1999,
intitulada "Estudo de uma infecção lentiviral
por SIVagm em duas espécies de macacos africanos".
312. Marcia Cristina Rachid de Lacerda, Tese de Mestrado,
Departamento de Medicina Preventiva, Faculdade de Medicina,
UFRJ,2000, intitulada "Efetividade da Terapia com dois
análogos de Nucleosídeos Inibidores da Transcriptase
Reversa em Pacientes com Infecção pelo HIV,
virgens de Tratamento".
313. Ana Maria Félix de Pinho, Tese de Doutorado, Departamento
de Medicina Preventiva, Faculdade de Medicina, UFRJ, 2000,
intitulada "Fatores de Risco Impacto na sobrevida em
uma Coorte de Pacientes com infecção pelo HIV."
314. Karla Regina Oliveira de Moura Ronchini,Tese de Mestrado,
Departamento de Medicina Preventiva, Faculdade de Medicina,
UFRJ, 2000, intitulada "Impacto Imunológico da
coinfecção pelo HIV e HTLV-1: resultados de
um estudo piloto".
315. Beatriz Gilda Jegerhorn Grinsztejn,Tese de Doutorado,
Departamento de Medicina Preventiva, Faculdade de Medicina,
UFRJ, 2001, intitulada "Prevalància de infecções
sexualmente transmissíveis e estudo dos fatores de
risco para infecção pelo HPV numa coorte de
mulheres infectadas pelo HIV no Rio de Janeiro".
316. Marcelo Vianna Vettore, Tese de Mestrado, Departamento
de Medicina Preventiva, Faculdade de Medicina, UFRJ, 2003,
intitulada "Correlação entre a carga viral
do HIV-1 no sangue e no trato genital feminino".
PARTICIPAÇÕES
EM BANCAS DE TESE
317. Instituto de Microbiologia da UFRJ, Banca Examinadora
da Defesa de Tese de Mestrado do Dr. Fernando Jorge Bornay
Llinares, 1991.
318. Disciplina de Clínica Medica, Faculdade de Medicina,
UFRJ, Banca Examinadora da Defesa de Tese de Mestrado do Dr.
Jose Rodolpho Rocco, 1991.
319. Instituto de Tisiologia e Pneumologia, UFRJ, Banca examinadora
da Defesa de Tese de Mestrado do Dr. Afranio Lineu Kritski,
1992.
320. Disciplina de Dermatologia, Faculdade de Medicina, UFRJ,
Banca examinadora da defesa de Tese de Mestrado da Prof. Monica
Manela-Azulay, 1992.
321. Disciplina de Doenças Infecciosas e Parasitárias,
Escola Paulista de Medicina, Banca examinadora da defesa de
Tese de Doutorado do Prof. Ricardo Sobhie Diaz, 1993.
322. Instituto de Biofísica da UFRJ. Banca examinadora
da defesa de tese de Mestrado do aluno Renato Augusto Damatta,
1993.
323. Escola Nacional de Saúde Pública da Fiocruz.
Banca examinadora da defesa de tese de Mestrado da aluna Mônica
Edelenyi Pinto, 2003.
(Voltar
para o topo)
|
